Evaluation of the effect of curcumin in improving patients with covid -19

INTERVENTION: Intervention 1: Intervention group: patients are given 3 curcumin capsules(500mg) daily after three meals. Intervention 2: Control group: Take 3 placebo (500 mg of lactose) daily for 3 weeks for 2 weeks. CONDITION: covid‐19. ; virus not identified U07.2 PRIMARY OUTCOME: C‐Reactive protein. Timepoint: First admission and one week after admission. Method of measurement: Agglutination method. Complete blood count. Timepoint: First admission and one week after admission. Method of measurement: cell counter. D‐Dimer test. Timepoint: First admission and one week after admission. Method of measurement: nephlometery. Duration of hospitalization. Timepoint: Patient discharge time or death. Method of measurement: patient medical records. Erythrocyte sedimentation rate. Timepoint: First admission and one week after admission. Method of measurement: sediment analyzer. LDH. Timepoint: First admission and one week after admission. Method of measurement: Spectrophotometric assay. Lung CT‐SCAN. Timepoint: First admission and one week after admission. Method of measurement: CT‐SCAN IMAGING. Partial thromboplastine time. Timepoint: First admission and one week after admission. Method of measurement: coagulometer. Prothrombine time. Timepoint: First admission and one week after admission. Method of measurement: coagulometer. INCLUSION CRITERIA: Satisfaction to participate in the study Aged 18‐70 years Real Time PCR or CT‐SCAN positive test